DexCom, Inc. (DXCM)
USD 59.82
(-3.2%)
USD 59.82
(-3.2%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 6.26 Billion USD | 16.19% |
| 2022 | 5.39 Billion USD | 10.86% |
| 2021 | 4.86 Billion USD | 13.36% |
| 2020 | 4.29 Billion USD | 79.14% |
| 2019 | 2.39 Billion USD | 25.0% |
| 2018 | 1.91 Billion USD | 111.92% |
| 2017 | 904.1 Million USD | 124.45% |
| 2016 | 402.8 Million USD | 37.95% |
| 2015 | 292 Million USD | 58.18% |
| 2014 | 184.6 Million USD | 50.69% |
| 2013 | 122.5 Million USD | 15.57% |
| 2012 | 106 Million USD | -12.01% |
| 2011 | 120.47 Million USD | 56.13% |
| 2010 | 77.16 Million USD | 64.36% |
| 2009 | 46.94 Million USD | 5.82% |
| 2008 | 44.36 Million USD | -42.57% |
| 2007 | 77.25 Million USD | 19.68% |
| 2006 | 64.55 Million USD | 13.8% |
| 2005 | 56.72 Million USD | 93.22% |
| 2004 | 29.35 Million USD | 41.37% |
| 2003 | 20.76 Million USD | 0.0% |
| 2001 | 8.64 Million USD | -39.84% |
| 2000 | 14.36 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 6.35 Billion USD | -6.55% |
| 2024 Q1 | 6.48 Billion USD | 3.48% |
| 2024 Q2 | 6.79 Billion USD | 4.89% |
| 2023 FY | 6.26 Billion USD | 16.19% |
| 2023 Q4 | 6.26 Billion USD | -5.03% |
| 2023 Q2 | 6.82 Billion USD | 23.66% |
| 2023 Q1 | 5.51 Billion USD | 2.3% |
| 2023 Q3 | 6.59 Billion USD | -3.29% |
| 2022 Q1 | 5.05 Billion USD | 3.98% |
| 2022 FY | 5.39 Billion USD | 10.86% |
| 2022 Q2 | 5.21 Billion USD | 3.17% |
| 2022 Q3 | 4.89 Billion USD | -6.1% |
| 2022 Q4 | 5.39 Billion USD | 10.05% |
| 2021 Q1 | 4.38 Billion USD | 2.31% |
| 2021 Q2 | 4.5 Billion USD | 2.6% |
| 2021 Q3 | 4.77 Billion USD | 6.04% |
| 2021 Q4 | 4.86 Billion USD | 1.84% |
| 2021 FY | 4.86 Billion USD | 13.36% |
| 2020 Q3 | 3.83 Billion USD | 8.84% |
| 2020 Q1 | 2.44 Billion USD | 2.21% |
| 2020 Q2 | 3.52 Billion USD | 43.87% |
| 2020 Q4 | 4.29 Billion USD | 11.93% |
| 2020 FY | 4.29 Billion USD | 79.14% |
| 2019 FY | 2.39 Billion USD | 25.0% |
| 2019 Q4 | 2.39 Billion USD | 9.58% |
| 2019 Q3 | 2.18 Billion USD | 5.8% |
| 2019 Q2 | 2.06 Billion USD | 4.66% |
| 2019 Q1 | 1.97 Billion USD | 3.03% |
| 2018 Q1 | 896.8 Million USD | -0.81% |
| 2018 Q3 | 1.11 Billion USD | 10.6% |
| 2018 Q4 | 1.91 Billion USD | 71.95% |
| 2018 FY | 1.91 Billion USD | 111.92% |
| 2018 Q2 | 1 Billion USD | 12.34% |
| 2017 Q2 | 795.6 Million USD | 70.29% |
| 2017 Q4 | 904.1 Million USD | 7.26% |
| 2017 FY | 904.1 Million USD | 124.45% |
| 2017 Q1 | 467.2 Million USD | 15.99% |
| 2017 Q3 | 842.9 Million USD | 5.95% |
| 2016 Q4 | 402.8 Million USD | 11.3% |
| 2016 FY | 402.8 Million USD | 37.95% |
| 2016 Q3 | 361.9 Million USD | 8.74% |
| 2016 Q2 | 332.8 Million USD | 11.16% |
| 2016 Q1 | 299.4 Million USD | 2.53% |
| 2015 Q2 | 218.4 Million USD | 15.37% |
| 2015 Q3 | 256.7 Million USD | 17.54% |
| 2015 Q4 | 292 Million USD | 13.75% |
| 2015 FY | 292 Million USD | 58.18% |
| 2015 Q1 | 189.3 Million USD | 2.55% |
| 2014 FY | 184.6 Million USD | 50.69% |
| 2014 Q2 | 139.7 Million USD | 11.85% |
| 2014 Q3 | 159.4 Million USD | 14.1% |
| 2014 Q4 | 184.6 Million USD | 15.81% |
| 2014 Q1 | 124.9 Million USD | 1.96% |
| 2013 Q4 | 122.5 Million USD | 11.26% |
| 2013 Q3 | 110.1 Million USD | 7.62% |
| 2013 FY | 122.5 Million USD | 15.57% |
| 2013 Q2 | 102.3 Million USD | 3.54% |
| 2013 Q1 | 98.8 Million USD | -6.79% |
| 2012 Q3 | 102.79 Million USD | -6.99% |
| 2012 Q4 | 106 Million USD | 3.12% |
| 2012 Q2 | 110.52 Million USD | -6.31% |
| 2012 Q1 | 117.96 Million USD | -2.09% |
| 2012 FY | 106 Million USD | -12.01% |
| 2011 Q1 | 66.55 Million USD | -13.75% |
| 2011 Q3 | 128.79 Million USD | -5.56% |
| 2011 Q4 | 120.47 Million USD | -6.46% |
| 2011 FY | 120.47 Million USD | 56.13% |
| 2011 Q2 | 136.36 Million USD | 104.9% |
| 2010 Q4 | 77.16 Million USD | 42.62% |
| 2010 Q1 | 68.31 Million USD | 45.51% |
| 2010 FY | 77.16 Million USD | 64.36% |
| 2010 Q2 | 60.56 Million USD | -11.34% |
| 2010 Q3 | 54.1 Million USD | -10.67% |
| 2009 FY | 46.94 Million USD | 5.82% |
| 2009 Q3 | 53.95 Million USD | -17.12% |
| 2009 Q4 | 46.94 Million USD | -12.99% |
| 2009 Q2 | 65.1 Million USD | -16.48% |
| 2009 Q1 | 77.94 Million USD | 75.69% |
| 2008 Q1 | 68.96 Million USD | -10.74% |
| 2008 FY | 44.36 Million USD | -42.57% |
| 2008 Q2 | 57.05 Million USD | -17.27% |
| 2008 Q4 | 44.36 Million USD | 3.0% |
| 2008 Q3 | 43.07 Million USD | -24.5% |
| 2007 Q2 | 96.52 Million USD | -8.47% |
| 2007 Q4 | 77.25 Million USD | -9.63% |
| 2007 FY | 77.25 Million USD | 19.68% |
| 2007 Q1 | 105.46 Million USD | 63.37% |
| 2007 Q3 | 85.48 Million USD | -11.44% |
| 2006 Q2 | 84.62 Million USD | 78.2% |
| 2006 Q3 | 75.53 Million USD | -10.74% |
| 2006 FY | 64.55 Million USD | 13.8% |
| 2006 Q4 | 64.55 Million USD | -14.54% |
| 2006 Q1 | 47.48 Million USD | -16.29% |
| 2005 Q3 | 64.27 Million USD | -8.28% |
| 2005 Q1 | 25.36 Million USD | 0.0% |
| 2005 Q2 | 70.07 Million USD | 176.28% |
| 2005 Q4 | 56.72 Million USD | -11.75% |
| 2005 FY | 56.72 Million USD | 93.22% |
| 2004 FY | 29.35 Million USD | 41.37% |
| 2003 FY | 20.76 Million USD | 0.0% |
| 2001 FY | 8.64 Million USD | -39.84% |
| 2000 FY | 14.36 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -19872.263% |
| BrainsWay Ltd. | 62.97 Million USD | -9848.072% |
| Cerus Corporation | 197.74 Million USD | -3067.921% |
| Envoy Medical, Inc. | 7.64 Million USD | -81896.073% |
| electroCore, Inc. | 16.38 Million USD | -38128.474% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -81341.758% |
| IceCure Medical Ltd | 16.41 Million USD | -38074.893% |
| Inogen, Inc. | 326.19 Million USD | -1820.483% |
| OrthoPediatrics Corp. | 449.58 Million USD | -1293.393% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -22872.131% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -37685.733% |
| MaxCyte, Inc. | 268.27 Million USD | -2235.113% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -77265.161% |
| Nexalin Technology, Inc. | 3.63 Million USD | -172384.716% |
| Orthofix Medical Inc. | 925.31 Million USD | -577.013% |
| PAVmed Inc | 33.11 Million USD | -18815.124% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | -4266.966% |
| RxSight, Inc. | 182.55 Million USD | -3331.663% |
| Sight Sciences, Inc. | 166.65 Million USD | -3659.053% |
| SI-BONE, Inc. | 230.42 Million USD | -2618.672% |
| TELA Bio, Inc. | 78.04 Million USD | -7926.471% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | -2386.83% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -58283.038% |
| Acutus Medical, Inc. | 53.96 Million USD | -11509.526% |
| Talis Biomedical Corporation | 98.34 Million USD | -6270.246% |
| Spectral AI, Inc. | 10.69 Million USD | -58490.535% |
| Nano-X Imaging Ltd. | 218.64 Million USD | -2765.107% |
| CVRx, Inc. | 115.22 Million USD | -5336.565% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | -10579.158% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -200991.212% |
| Bioventus Inc. | 810.91 Million USD | -672.527% |
| Venus Concept Inc. | 93.65 Million USD | -6588.983% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -24251.798% |
| LivaNova PLC | 2.42 Billion USD | -157.845% |
| 908 Devices Inc. | 202.98 Million USD | -2986.249% |
| Alphatec Holdings, Inc. | 805.2 Million USD | -677.998% |
| Nemaura Medical Inc. | 14.56 Million USD | -42915.861% |
| NeuroPace, Inc. | 107.65 Million USD | -5719.268% |
| LENSAR, Inc. | 69.58 Million USD | -8902.659% |
| Apyx Medical Corporation | 79.24 Million USD | -7805.729% |
| Cutera, Inc. | 346.29 Million USD | -1709.028% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -14809.796% |
| BioSig Technologies, Inc. | 1.79 Million USD | -348314.905% |
| Anika Therapeutics, Inc. | 270.63 Million USD | -2214.767% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -14584.372% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | -65.64% |
| Axonics, Inc. | 719.92 Million USD | -770.163% |
| Outset Medical, Inc. | 313.8 Million USD | -1896.329% |
| IRIDEX Corporation | 34.43 Million USD | -18091.718% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | -1447.872% |
| IRadimed Corporation | 92.15 Million USD | -6697.705% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -119132.965% |
| INVO Bioscience, Inc. | 20.88 Million USD | -29891.21% |
| Telesis Bio, Inc. | 70.41 Million USD | -8797.047% |
| Viemed Healthcare, Inc. | 154.1 Million USD | -3965.151% |
| Varex Imaging Corporation | 1.24 Billion USD | -401.32% |
| Quipt Home Medical Corp. | 247.4 Million USD | -2432.052% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -67187.863% |
| Pulmonx Corporation | 178.95 Million USD | -3400.679% |
| Dynatronics Corporation | 25.94 Million USD | -24049.441% |
| Modular Medical, Inc. | 13.8 Million USD | -45271.913% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -58299.366% |
| Semler Scientific, Inc. | 78.06 Million USD | -7924.723% |
| InMode Ltd. | 863.28 Million USD | -625.658% |
| Bruker Corporation | 4.24 Billion USD | -47.403% |
| Cytosorbents Corporation | 53.26 Million USD | -11661.97% |
| Align Technology, Inc. | 6.08 Billion USD | -2.969% |
| Viveve Medical, Inc. | 25.91 Million USD | -24075.124% |
| ZimVie Inc. | 1.2 Billion USD | -419.727% |
| Movano Inc. | 9.42 Million USD | -66395.064% |
| Cytek Biosciences, Inc. | 497.66 Million USD | -1158.768% |
| Nexalin Technology, Inc. | 3.63 Million USD | -172384.716% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | -10579.158% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | -557.581% |
| Profound Medical Corp. | 43.68 Million USD | -14239.723% |
| Insulet Corporation | 2.58 Billion USD | -142.041% |
| enVVeno Medical Corporation | 48.63 Million USD | -12780.642% |
| Surmodics, Inc. | 185.73 Million USD | -3272.852% |
| iCAD, Inc. | 41.41 Million USD | -15025.066% |
| Nuwellis, Inc. | 9.77 Million USD | -64019.754% |
| Biotricity, Inc. | 5.94 Million USD | -105316.377% |
| iRhythm Technologies, Inc. | 433.14 Million USD | -1346.286% |
| Aethlon Medical, Inc. | 8.24 Million USD | -75870.333% |
| InspireMD, Inc. | 47.64 Million USD | -13048.836% |
| PAVmed Inc. | 33.11 Million USD | -18815.124% |
| BIOLASE, Inc. | 35.1 Million USD | -17747.07% |
| Beyond Air, Inc. | 56.96 Million USD | -10897.876% |
| FONAR Corporation | 214.24 Million USD | -2823.976% |
| AxoGen, Inc. | 196.82 Million USD | -3082.744% |
| Vivani Medical, Inc. | 45.79 Million USD | -13578.844% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | -2125.89% |
| Inari Medical, Inc. | 674.23 Million USD | -829.127% |
| UFP Technologies, Inc. | 404.13 Million USD | -1450.097% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -26673.013% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -65820.504% |
| Tenon Medical, Inc. | 6.34 Million USD | -98631.284% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -66494.026% |
| Co-Diagnostics, Inc. | 103.64 Million USD | -5944.03% |
| AdaptHealth Corp. | 4.61 Billion USD | -35.6% |
| Sintx Technologies, Inc. | 15.36 Million USD | -40671.233% |
| NanoVibronix, Inc. | 6.67 Million USD | -93764.249% |
| Quanterix Corporation | 425.01 Million USD | -1373.962% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -67187.863% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -11559.873% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | -258.789% |
| TransMedics Group, Inc. | 706.04 Million USD | -787.264% |
| ReWalk Robotics Ltd. | 63.19 Million USD | -9813.438% |
| NeuroMetrix, Inc. | 21.42 Million USD | -29139.969% |
| Hyperfine, Inc. | 94.19 Million USD | -6550.283% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | -2231.923% |
| Biomerica, Inc. | 9.25 Million USD | -67595.051% |
| Bone Biologics Corporation | 3.73 Million USD | -167500.246% |
| AVITA Medical, Inc. | 144.33 Million USD | -4240.1% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -128573.31% |
| Silk Road Medical, Inc | 265.3 Million USD | -2261.209% |